Search Results - "Huh, W. S."

Refine Results
  1. 1

    Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions by Ahn, W-S, Yoo, J, Huh, S-W, Kim, C-K, Lee, J-M, Namkoong, S-E, Bae, S-M, Lee, I P

    Published in European journal of cancer prevention (01-10-2003)
    “…We investigated clinical efficacy of green tea extracts (polyphenon E; poly E and (-)-epigallocatechin-3-gallate [EGCG]) delivered in a form of ointment or…”
    Get full text
    Journal Article
  2. 2

    Lifetime-limiting defects in n − 4H-SiC epilayers by Klein, P. B., Shanabrook, B. V., Huh, S. W., Polyakov, A. Y., Skowronski, M., Sumakeris, J. J., O'Loughlin, M. J.

    Published in Applied physics letters (30-01-2006)
    “…Low-injection minority carrier lifetimes (MCLs) and deep trap spectra have been investigated in n − 4H-SiC epilayers of varying layer thicknesses, in order to…”
    Get full text
    Journal Article
  3. 3

    Rabbit Antithymocyte Globulin Compared with Basiliximab in Kidney Transplantation: A Single-Center Study by Kim, J.M, Jang, H.R, Kwon, C.H.D, Huh, W.S, Kim, G.S, Kim, S.J, Joh, J.W, Oh, H.Y

    Published in Transplantation proceedings (2012)
    “…Abstract Background Induction therapy is used to reduce the incidence of acute rejection and to prevent or treat delayed graft function. We compared…”
    Get full text
    Journal Article Conference Proceeding
  4. 4

    Urinary angiotensinogen levels reflect the severity of renal histopathology in patients with chronic kidney disease by Kim, S M, Jang, H R, Lee, Y-J, Lee, J E, Huh, W S, Kim, D J, Oh, H Y, Kim, Y-G

    Published in Clinical nephrology (01-08-2011)
    “…Recent studies have suggested that urinary angiotensinogen (AGT) reflects the activity of the intrarenal renin angiotensin system (RAS), which is involved in…”
    Get more information
    Journal Article
  5. 5

    Hormonal Differences Between Female Kidney Transplant Recipients and Healthy Women With the Same Gynecologic Conditions by Kim, J.M, Song, R.K, Kim, M.-J, Lee, D.Y, Jang, H.R, Kwon, C.H.D, Huh, W.S, Kim, G.S, Kim, S.J, Choi, D.S, Joh, J.-W, Lee, S.-K, Oh, H.Y

    Published in Transplantation proceedings (01-04-2012)
    “…Abstract Background End-stage renal disease is associated with severe abnormalities in reproductive function. However, the abnormalities are reversed by…”
    Get full text
    Journal Article Conference Proceeding
  6. 6

    Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation by Lee, K.W., Kim, S.J., Lee, D.S., Lee, H.H., Joh, J.W., Lee, S.K., Oh, H.Y., Kim, D.J., Kim, Y.G., Huh, W.S., Oh, W.I., Lee, B.B.

    Published in Transplantation proceedings (01-09-2004)
    “…Because it is well known that kidney transplant recipients with preformed lymphocytotoxic antibodies against HLA antigens have increased graft rejection rates,…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Short-Term Outcomes of ABO-Incompatible Living Donor Kidney Transplantation With Uniform Protocol: Significance of Baseline Anti-ABO Titer by Lee, K.W, Park, J.B, Oh, D.K, Na, B.G, Choi, J.Y, Cho, W.T, Lee, S.H, Park, H.J, Cho, D, Huh, W.S, Kim, S.J

    Published in Transplantation proceedings (01-04-2016)
    “…Abstract Antibody-mediated rejection (AMR) is one of the major causes of poor outcomes in ABO-incompatible kidney transplantation (ABOi KT). Studies…”
    Get full text
    Journal Article
  8. 8

    Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients by Kim, S.J., Lee, K.W., Lee, D.S., Lee, H.H., Lee, S.K., Kim, B., Huh, W.S., Oh, H.Y., Joh, J.W.

    Published in Transplantation proceedings (01-09-2004)
    “…The introduction of new immunosuppressants has prompted trials of steroid withdrawal. However, several groups have reported a higher incidence of rejection. We…”
    Get full text
    Journal Article Conference Proceeding
  9. 9

    Polymerase chain reaction for the diagnosis of human polyomavirus-associated nephropathy in renal transplant recipients by Lee, K.W., Lee, H.H., Lee, D.S., Kim, S.J., Joh, J.W., Oh, H.Y., Kim, J.W., Kim, Y.G., Huh, W.S., Kim, D.J., Lee, S.K., Lee, B.B.

    Published in Transplantation proceedings (01-09-2004)
    “…Human polyomavirus type BK may be related to interstitial nephropathy or renal-allograft dysfunction. Patients with nephropathy due to infection with human…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Prognostic factors affecting graft and patient survival in cadaveric and living kidney transplantation by Kim, S.J., Lee, H.H., Lee, D.S., Lee, K.W., Joh, J.W., Woo, D.H., Kwon, G.Y., Oh, H.Y., Kim, Y.G., Huh, W.S., Kim, D.J., Kim, G.S., Lee, S.K., Lee, B.B.

    Published in Transplantation proceedings (01-09-2004)
    “…Numerous studies have reported various prognostic factors that affect graft and patient survival in living and cadaveric donor kidney transplantation (KT). The…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Comparison of Cadaveric Kidney Transplantation From In-center and External Center Donors by Cho, A.J, Jang, H.R, Lee, J.E, Huh, W.S, Kim, Y.-G, Oh, H.Y, Kim, D.J

    Published in Transplantation proceedings (01-12-2014)
    “…Abstract Introduction Renal transplantation is the best treatment modality for end-stage renal disease. We investigated the effects of donor source on renal…”
    Get full text
    Journal Article
  12. 12

    Presence of Vesicoureteral Reflux in the Graft Kidney Does Not Adversely Affect Long-Term Graft Outcome in Kidney Transplant Recipients by Lee, S, Moon, H.H, Kim, T.-S, Roh, Y, Song, S, Shin, M, Kim, J.M, Kwon, C.H.D, Joh, J.-W, Lee, S.-K, Huh, W.S, Oh, H.Y, Kim, S.-J

    Published in Transplantation proceedings (01-10-2013)
    “…Abstract Introduction We studied the incidence of vesicoureteral reflux (VUR) in the graft kidney and its effect on the occurrence of urinary tract infection…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16

    A fully validated HPLC method for the simultaneous determination of acitretin and etretinate in plasma and its application to a pharmacokinetic study in healthy Korean subjects by Park, H-D, Kim, H-K, Chun, M-R, Kim, J-W, Kim, D-W, Lee, J-H, Huh, W S, Youn, J-I, Kim, H-G, Kim, Y G, Kim, M-H, Lee, S-Y

    “…Acitretin is used for the treatment of psoriasis. The purpose of this study was to validate an HPLC method for the determination of acitretin and etretinate…”
    Get full text
    Journal Article
  17. 17

    Necrosis-like death with plasma membrane damage against cervical cancer cells by photodynamic therapy by Ahn, W S, Bae, S M, Huh, S W, Lee, J M, Namkoong, S E, Han, S-J, Kim, C K, Kim, J-K, Kim, Y-W

    “…In order to elucidate the antitumor effect of photodynamic therapy (PDT) using the photosensitizing agent hematoporphyrin derivative (Photogem) and a diode…”
    Get more information
    Journal Article
  18. 18

    Beat-frequency locking of ultradense WDM channels using a tunable laser source by Kim, S.-Y., Huh, S.-W., Lee, S.-H., Seo, K.-H., Lee, J.-S.

    Published in IEEE photonics technology letters (01-05-2004)
    “…We present a beat-frequency-locking method that uses a tunable laser source (TLS) for the alignment of ultradense (UD) wavelength-division-multiplexing (WDM)…”
    Get full text
    Journal Article
  19. 19

    Modification of a Ziegler-Natta catalyst with a metallocene catalyst and its olefin polymerization behavior by Ahn, Tae Oan, Hong, Sung Chul, Huh, Wan Soo, Lee, Young-Chul, Lee, Dong-Ho

    Published in Polymer engineering and science (01-07-1999)
    “…A Ziegler‐Natta catalyst was modified with a metallocene catalyst and its polymerization behavior was examined. In the modification of the TiCl4 catalyst…”
    Get full text
    Journal Article
  20. 20

    Erlotinib-associated rash correlates with plasma levels at steady state by Strother, R. M., Jones, D. R., Skaar, T., Huh, W. S., Porter, J., Foster, A., Sweeney, C.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 13008 Background: Erlotinib is a small molecule epidermal growth factor receptor tyrosine kinase inhibitor that is approved for non-small cell…”
    Get full text
    Journal Article